anmelden
FTSE All-Share
5.796,02
PKT
+9,62
PKT
+0,17
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 07.02.24 | BP Underweight | JP Morgan Chase & Co. | |
| 07.02.24 | Vodafone Group Neutral | JP Morgan Chase & Co. | |
| 06.02.24 | BP Overweight | Barclays Capital | |
| 06.02.24 | BP Underweight | JP Morgan Chase & Co. | |
| 06.02.24 | BP Outperform | RBC Capital Markets | |
| 06.02.24 | BP Hold | Jefferies & Company Inc. | |
| 06.02.24 | GSK Buy | UBS AG | |
| 06.02.24 | Vodafone Group Buy | UBS AG | |
| 06.02.24 | BP Buy | UBS AG | |
| 06.02.24 | BAT Buy | Jefferies & Company Inc. | |
| 06.02.24 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 05.02.24 | BP Outperform | RBC Capital Markets | |
| 05.02.24 | Vodafone Group Buy | Deutsche Bank AG | |
| 05.02.24 | GSK Buy | Deutsche Bank AG | |
| 05.02.24 | Vodafone Group Neutral | JP Morgan Chase & Co. | |
| 05.02.24 | Vodafone Group Equal Weight | Barclays Capital | |
| 05.02.24 | National Grid Buy | Jefferies & Company Inc. | |
| 02.02.24 | Glencore Equal Weight | Barclays Capital | |
| 02.02.24 | GSK Equal Weight | Barclays Capital | |
| 02.02.24 | HSBC Overweight | Barclays Capital | |
| 02.02.24 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 01.02.24 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 01.02.24 | Diageo Underperform | RBC Capital Markets | |
| 01.02.24 | Glencore Buy | Jefferies & Company Inc. | |
| 01.02.24 | Shell (ex Royal Dutch Shell) Overweight | Barclays Capital | |
| 01.02.24 | Unilever Overweight | Barclays Capital | |
| 01.02.24 | GSK Halten | DZ BANK | |
| 01.02.24 | Glencore Outperform | RBC Capital Markets | |
| 01.02.24 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 01.02.24 | Shell (ex Royal Dutch Shell) Neutral | UBS AG | |
| 01.02.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 01.02.24 | GSK Buy | Deutsche Bank AG | |
| 01.02.24 | GSK Buy | Deutsche Bank AG | |
| 31.01.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 31.01.24 | GSK Buy | UBS AG | |
| 31.01.24 | AstraZeneca Sell | UBS AG | |
| 31.01.24 | Diageo Overweight | Barclays Capital | |
| 31.01.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 31.01.24 | Diageo Sell | UBS AG | |
| 31.01.24 | Diageo Outperform | Bernstein Research |
